Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.7682
-0.0420 (-5.18%)
At close: Aug 18, 2026, 4:00 PM EDT
0.7600
-0.0082 (-1.07%)
After-hours: Aug 18, 2026, 4:21 PM EDT
Daré Bioscience Revenue
Daré Bioscience had revenue of $187.55K in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $1.37M. In the year 2025, Daré Bioscience had annual revenue of $1.03M with 10,429.36% growth.
Revenue (ttm)
$1.37M
Revenue Growth
+10,429.36%
P/S Ratio
8.89
Revenue / Employee
$56,914
Employees
24
Market Cap
11.51M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.03M | 1.02M | 10,429.36% |
| Dec 31, 2024 | 9.78K | -2.80M | -99.65% |
| Dec 31, 2023 | 2.81M | -7.19M | -71.92% |
| Dec 31, 2022 | 10.00M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | 80.00K | 74.00K | 1,233.33% |
| Dec 31, 2013 | 6.00K | -619.00K | -99.04% |
| Dec 31, 2012 | 625.00K | 619.00K | 10,316.67% |
| Dec 31, 2011 | 6.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Moolec Science | 7.83M |
| SeaStar Medical Holding | 1.71M |
| BioLineRx | 1.40M |
| Lexaria Bioscience | 194.00K |
| Senti Biosciences Holdings | 55.00K |
DARE News
- 7 hours ago - DARÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 Over 50: Innovation” List - GlobeNewsWire
- 2 days ago - Dare Bioscience announces pricing of $6M registered direct offering - TheFly
- 4 days ago - Daré Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 5 days ago - Daré Bioscience Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - Daré Bioscience Quarterly report: Q2 2026 - Filings
- 5 days ago - Daré Bioscience Earnings release: Q2 2026 - Filings
- 5 days ago - Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women's Health Strategy Advances - GlobeNewsWire
- 12 days ago - Daré Bioscience to Host Second Quarter 2026 Financial Results and Company Update Conference Call and Webcast on August 13, 2026 - GlobeNewsWire